Learn how the waveRAPID, a Creoptix technology, supports screening of 80 known kinase inhibitors to p38.
Our team discuss:
- the screening process
- Ligand immobilization
- Positive control establishment
- Review of screening results (non binding, non-specific binders, binders/HITs)
- validation of HITs using Multicycle Kinetics